Navigation Links
PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Shares and Corrects Ex-Dividend Trading Date for Common Shares
Date:2/7/2008

PEMBROKE, Bermuda, Feb. 7 /PRNewswire-FirstCall/ -- PartnerRe Ltd. (NYSE: PRE) announced that its Board of Directors has declared a dividend for the period December 1, 2007 - February 29, 2008 of $0.421875 per share on the Company's 6.75% Series C Cumulative Redeemable Preferred Shares, and $0.40625 per share on the Company's 6.5% Series D Cumulative Redeemable Preferred Shares. The dividends will be payable on March 3, 2008, to shareholders of record on February 22, 2008.

PartnerRe Ltd. is a leading global reinsurer, providing multi-line reinsurance to insurance companies. The Company, through its wholly owned subsidiaries, also offers alternative risk products that include weather and credit protection to financial, industrial and service companies. Risks reinsured include property, casualty, motor, agriculture, aviation/space, catastrophe, credit/surety, engineering, energy, marine, specialty property, specialty casualty, multiline and other lines, life/annuity and health, and alternative risk products. For the year ended December 31, 2007, total revenues were $4.2 billion, total assets were $16.0 billion, and at December 31, 2007 total capital was $5.2 billion and total shareholders' equity was $4.3 billion.

PartnerRe on the Internet: http://www.partnerre.com

Contacts: PartnerRe Ltd. Sard Verbinnen & Co.

(441) 292-0888 (212) 687-8080

Investor Contact: Robin Sidders Drew Brown/Jane Simmons

Media Contact: Celia Powell


'/>"/>
SOURCE PartnerRe Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend
4. Mylan Declares Quarterly Preferred Stock Dividend
5. NHP Increases Its Quarterly Common Dividend by $0.03 and Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
6. BD Board Declares Dividend
7. Assurant Board of Directors Declares Quarterly Dividend of $0.12 per Share
8. Wyeth Declares Common and Preferred Stock Dividends
9. STERIS Corporation Declares Regular Quarterly Dividend
10. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
11. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
Breaking Medicine Technology: